Acrobiosystems for English
icon_bulk_orderConsulta masiva/Pedido rápido
user
  1. Cuadro de mandos
  2. Mi perfil
  3. Mi dirección
  4. Mis pedidos
  5. Afiliación a Acro
Iniciar sesión Registro
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
No hay productos en el carro de la compra
Mi carro|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Casa > GDNF

GDNF

Brief Information

Name:Glial cell line-derived neurotrophic factors
Target Synonym:Glial Cell Line-Derived Neurotrophic Factors
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:NDA/BLA

Product ListCompare or Buy

Product> Filter Results
Por estado del producto :
Por categoría de producto :
Por especies :
Por etiqueta :
Por Conjugado::
Cat. No. Especies Descripción del producto Estructura Pureza Característica
GDF-M5245 Mouse Mouse GDNF / ATF Protein, His Tag (MALS verified)
GDF-M5245-structure
GDF-M5245-sds
GDF-H5219 Human Human GDNF / ATF / hGDNF Protein, premium grade
GDF-H5219-structure
GDF-H5219-sds
ACRO Quality

Part of Bioactivity data

GDF-M5245-MALS-HPLC
GDNF MALS images

The purity of Mouse GDNF, His Tag (Cat. No. GDF-M5245) is more than 90% and the molecular weight of this protein is around 40-50 kDa verified by SEC-MALS.

GDF-H5219-ELISA
GDNF ELISA

Immobilized Human GDNF Protein, premium grade (Cat. No. GDF-H5219) at 2 μg/mL (100 μL/well) can bind Human GFR alpha-1, His Tag (Cat. No. GF1-H5224) with a linear range of 0.2-4 ng/mL (QC tested).

Protocol

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
AAV2-GDNF AB-1005; AMT-140 Phase 2 Clinical Lund University Foundation, National Institute Of Neurological Disorders And Stroke, Uniqure Biopharma Bv, Uc San Francisco Parkinson Disease; Multiple System Atrophy Details
NRO-1 NRO-1; SI-01 Phase 2 Clinical Senju Pharmaceutical Co Ltd Xerophthalmia Details
AMT-130 AAV5-miSNP15; AAV5-miSNP7; AMT-130; AAV5-miHtt12 Phase 2 Clinical Amsterdam Molecular Therapeutics, Uniqure Huntington Disease Details
AAV2-GDNF AB-1005; AMT-140 Phase 2 Clinical Lund University Foundation, National Institute Of Neurological Disorders And Stroke, Uniqure Biopharma Bv, Uc San Francisco Parkinson Disease; Multiple System Atrophy Details
NRO-1 NRO-1; SI-01 Phase 2 Clinical Senju Pharmaceutical Co Ltd Xerophthalmia Details
AMT-130 AAV5-miSNP15; AAV5-miSNP7; AMT-130; AAV5-miHtt12 Phase 2 Clinical Amsterdam Molecular Therapeutics, Uniqure Huntington Disease Details

This web search service is supported by Google Inc.

totop
Call us
Call us

Germany+49 800 0826645

United Kingdom+44 808 281 3436

Netherlands+31 800 0224992

Switzerland+41 800 040 012

France+33 800 90 78 85

Sweden+46 20 12 76 94

Denmark+45 80 83 07 62

Belgium+32 800 27 125

Email
Correo electrónico
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland
linkedin twitter facebook youtube

Dejar un mensaje

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap